Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer

Lung cancer is the leading cause of cancer death in both sexes worldwide and has a predicted 5-year survival rate of <20%. Immunotherapy targeting immune checkpoints such as the programmed death 1 (PD-1) signaling pathway has led to a shift of paradigm in the treatment of advanced non–small-cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Tøndell, Anders, Wahl, Sissel Gyrid Freim, Sponaas, Anne-Marit, Sørhaug, Sveinung, Børset, Magne, Haug, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872777/
https://www.ncbi.nlm.nih.gov/pubmed/31733591
http://dx.doi.org/10.1016/j.tranon.2019.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872777/
https://www.ncbi.nlm.nih.gov/pubmed/31733591
http://dx.doi.org/10.1016/j.tranon.2019.09.003

Ejemplares similares